Literature DB >> 15785089

A strategy for early detection of recurrent hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization.

Young-Hwa Chung1.   

Abstract

OBJECTIVES: To find a better surveillance method in detecting recurrent HCCs, patterns of recurrences following initial remission by transcatheter arterial chemoembolization (TACE) were evaluated.
METHODS: Of 235 consecutive HCC patients who underwent TACE, 69 with initial remission were followed for >12 months. We compared the recurrence rates according to the characteristics of original HCCs and analyzed the locations of recurrent HCCs. We also evaluated the diagnostic efficacies of CT scan with serum AFP, angiography and Lipiodol CT scan in detecting recurrent HCCs.
RESULTS: In 37 of 69, recurrent HCCs were detected after a median period of 17 months. Multinodular HCCs recurred more frequently than single-nodular HCCs. All of 5 patients with portal vein thrombosis recurred. Although 46% of recurrences were adjacent to original tumors, 62% were separated from them (8% at both). HCC with heterogeneous lipiodol uptake frequently recurred adjacent to original tumors. Only 18 of 37 recurrent HCCs were initially detected by serum AFP and CT scans; 17 by angiography, 2 only by lipiodol CT scan.
CONCLUSIONS: Regular angiography may be valuable in detecting recurrent HCCs, especially in multinodular HCC. HCC with heterogeneous lipiodol uptake should be treated in combination with local ablation therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15785089     DOI: 10.1159/000082094

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  5 in total

1.  Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival.

Authors:  Dong Ho Lee; Jeong Min Lee; Pyo Nyun Kim; Yun-Jin Jang; Tae Wook Kang; Hyunchul Rhim; Jung Wook Seo; Young Joon Lee
Journal:  Eur Radiol       Date:  2019-02-15       Impact factor: 5.315

2.  Transcatheter arterial chemoembolization combined with CT-guided percutaneous thermal ablation versus hepatectomy in the treatment of hepatocellular carcinoma.

Authors:  Sheng Li; Liang Zhang; Zhi-Mei Huang; Pei-Hong Wu
Journal:  Chin J Cancer       Date:  2015-06-10

3.  The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE.

Authors:  Jung Hee Kim; Dong Hyun Sinn; Sung Wook Shin; Sung Ki Cho; Wonseok Kang; Geum-Youn Gwak; Yong-Han Paik; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Moon Seok Choi
Journal:  Clin Mol Hepatol       Date:  2017-03-07

4.  Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma - 2020 Guangzhou Recommendations.

Authors:  Qi-Feng Chen; Wang Li; Simon Chun-Ho Yu; Yi-Hong Chou; Hyunchul Rhim; Xiaoming Yang; Lujun Shen; Annan Dong; Tao Huang; Jinhua Huang; Fujun Zhang; Weijun Fan; Ming Zhao; Yangkui Gu; Zhimei Huang; Mengxuan Zuo; Bo Zhai; Yueyong Xiao; Ming Kuang; Jiaping Li; Jianjun Han; Wei Song; Jie Ma; Peihong Wu
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

5.  Radiofrequency ablation for viable hepatocellular carcinoma around retained iodized oil after transcatheter arterial chemoembolization: usefulness of biplane fluoroscopy plus ultrasound guidance.

Authors:  Ji Hye Min; Min Woo Lee; Hyunchul Rhim; Dongil Choi; Young-Sun Kim; Young Jun Kim; Dong Ik Cha; Hyo K Lim
Journal:  Korean J Radiol       Date:  2012-10-12       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.